NR1H4 and fatty liver disease: In this context, intestinal FXR appears to be responsible for promoting systemic insulin resistance, as intestine-specific inhibition of FXR led to a reduced ceramide synthesis and therefore prevented and reversed the development of fatty liver disease [115], possibly by preventing adipose inflammation caused by bile acids produced by the gut microbiota [114].